Court Opinion

ID: 2806160
Source: CourtListenerOpinion
Date Created: 2015-06-06 05:05:19.960698+00
Date Added: 2024-06-11T11:29:58.779909
License: Public Domain

In the United States Court of Federal Claims
                             OFFICE OF SPECIAL MASTERS
                                       No. 14-118V
                                   Filed: May 12, 2015
                                  (Not to be published)

***********************
CARRIN SIMMONS, parent of E.S.,        *
a minor,                               *
                                       *
                   Petitioner,         *      Joint Stipulation on Damages; HPV
v.                                     *      Vaccine; Chronic Urticaria.
                                       *
SECRETARY OF HEALTH                    *
AND HUMAN SERVICES,                    *
                                       *
                   Respondent.         *
                                       *
***********************
Ronald C. Homer, Conway, Homer & Chin-Caplan, P.C., Boston, MA for petitioner.
Ann D. Martin, United States Department of Justice, Washington, DC for respondent.

                         DECISION ON JOINT STIPULATION1

Gowen, Special Master:

      On February 10, 2014, Carrin Simmons (“petitioner”) filed a petition on behalf of
her minor child, E.S., for compensation under the National Vaccine Injury Compensation
Program, 42 U.S.C. §300aa-10, et seq.2 [the “Vaccine Act” or “Program”]. Petitioner
1
  Because this unpublished ruling contains a reasoned explanation for the action in this case, I
intend to post this ruling on the United States Court of Federal Claims' website, in accordance with
the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified as
amended at 44 U.S.C. § 3501 note (2006)). In accordance with Vaccine Rule 18(b), petitioner has
14 days to identify and move to delete medical or other information, the disclosure of which would
constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material
fits within this definition, I will delete such material from public access.
2
 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter,
for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of
42 U.S.C. § 300aa (2006).

                                                 1
alleged that as a result of receiving a Human Papillomavirus (“HPV”) vaccine on July 28,
2011 and September 28, 2011, E.S. developed chronic urticaria. Stipulation at ¶ 1-2, 4.
Further, petitioner alleged that E.S. experienced residual effects of this injury for more than
six months. Id. at ¶4.

       On May 11, 2015, the parties filed a stipulation in which they state that a decision
should be entered awarding compensation. Respondent denies that the HPV vaccinations
caused E.S.’s chronic urticaria or any other injury. Id. at ¶ 6. Nevertheless, the parties
agree to the joint stipulation, attached hereto as Appendix A. The undersigned finds the
stipulation reasonable and adopts it as the decision of the Court in awarding damages, on
the terms set forth therein.

       The parties have agreed that petitioner shall receive an amount sufficient to purchase
an annuity contract described in paragraph ten of the attached stipulation. Pursuant to the
terms therein, the undersigned awards petitioner the following compensation for all
damages that would be available under 42 U.S.C. § 300aa-15(a):

       1. An amount sufficient to purchase an annuity contract from a life insurance
          company, meeting the criteria described in paragraph 9, pursuant to which
          the life insurance company agrees to make payments periodically to E.S. as
          follows:

               a. $30,035.44 payable in a certain lump sum on April 1, 2018; and

               b. $36,011.38 payable in a certain lump sum on July 1, 2022.

       The clerk of the court is directed to enter judgment in accordance with this
decision.3

IT IS SO ORDERED.

                                     s/Thomas L. Gowen
                                     Thomas L. Gowen
                                     Special Master

3
  Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party filing a notice
renouncing the right to seek review.

                                                2
             IN THE UNITED STATES COURT OF FEDERAL CLAIMS
                        OFFICE OF SPECIAL MASTERS
____________________________________
                                     )
CARRIN SIMMONS, parent of E.S., a    )
minor,                               )
                                     )
            Petitioner,              )
                                     )  No. 14-118V
       v.                            )  Special Master Gowen
                                     )  ECF
SECRETARY OF HEALTH AND              )
HUMAN SERVICES,                      )
                                     )
            Respondent.              )
____________________________________)

                                            STIPULATION

          The parties hereby stipulate to the following matters:

          1. On behalf of her daughter, E.S., petitioner filed a petition for vaccine compensation

under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10 to 34 (the

“Vaccine Program”). The petition seeks compensation for injuries allegedly related to E.S.’s

receipt of the Human Papillomavirus (“HPV”) vaccine, which vaccine is contained in the

Vaccine Injury Table (the “Table”), 42 C.F.R. § 100.3(a).

          2. E.S. received her immunizations on July 28, 2011, and September 28, 2011.

          3. The vaccines were administered within the United States.

          4. Petitioner alleges that the HPV vaccine caused E.S. to develop chronic urticaria, and

that E.S. experienced residual effects of this injury for more than six months.

          5. Petitioner represents that there has been no prior award or settlement of a civil action

for damages on behalf of E.S. as a result of her condition.

          6. Respondent denies that the vaccine(s) caused E.S.’s chronic urticaria or any other

injury.
       7. Maintaining their above-stated positions, the parties nevertheless now agree that the

issues between them shall be settled and that a decision should be entered awarding the

compensation described in paragraph 8 of this Stipulation.

       8. As soon as practicable after an entry of judgment reflecting a decision consistent with

the terms of this Stipulation, and after petitioner has filed an election to receive compensation

pursuant to 42 U.S.C. § 300aa-21(a)(1), the Secretary of Health and Human Services will issue

the following vaccine compensation payment for all damages that would be available under 42

U.S.C. §300aa-15(a):

       An amount sufficient to purchase the annuity contract described in paragraph 10 below,
       paid to the life insurance company from which the annuity will be purchased (the “Life
       Insurance Company”).

       9. The Life Insurance Company must have a minimum of $250,000,000.00 capital and

surplus, exclusive of any mandatory security valuation reserve. The Life Insurance Company

must have one of the following ratings from two of the following rating organizations:

       a.      A.M. Best Company: A++, A+, A+g, A+p, A+r, or A+s;

       b.      Moody’s Investor Service Claims Paying Rating: Aa3, Aa2, Aa1, or Aaa;

       c.      Standard and Poor’s Corporation Insurer Claims-Paying Ability Rating: AA-,
               AA, AA+, or AAA;

       d.      Fitch Credit Rating Company, Insurance Company Claims Paying Ability Rating:
               AA-, AA, AA+, or AAA.

       10. The Secretary of Health and Human Services agrees to purchase an annuity contract

from the Life Insurance Company for the benefit of E.S., pursuant to which the Life Insurance

Company will agree to make payments periodically to E.S., as follows:

       a. $30,035.44 payable in a certain lump sum on April 1, 2018.

       b. $36,011.38 payable in a certain lump sum on July 1, 2022.

                                                 2
The payments provided for in this paragraph 10 shall be made as set forth above. Should E.S.

predecease the exhaustion of any certain payments set forth above, any remaining certain

payments shall be made to her estate. Written notice to the Secretary of Health and Human

Services and to the Life Insurance Company shall be provided within twenty (20) days of E.S.’s

death.

         11. The annuity contract will be owned solely and exclusively by the Secretary of Health

and Human Services and will be purchased as soon as practicable following the entry of a

judgment in conformity with this Stipulation. The parties stipulate and agree that the Secretary

of Health and Human Services and the United States of America are not responsible for the

payment of any sums other than the amounts set forth in paragraph 8 herein and the amounts

awarded pursuant to paragraph 12 herein, and that they do not guarantee or insure any of the

future annuity payments. Upon the purchase of the annuity contract, the Secretary of Health and

Human Services and the United States of America are released from any and all obligations with

respect to future annuity payments.

         12. As soon as practicable after the entry of judgment on entitlement in this case, and

after petitioner has filed both a proper and timely election to receive compensation pursuant to

42 U.S.C. § 300aa-21(a)(1), and an application, the parties will submit to further proceedings

before the special master to award reasonable attorneys’ fees and costs incurred in proceeding

upon this petition.

         13. Petitioner and her attorney represent that compensation to be provided pursuant to

this Stipulation is not for any items or services for which the Program is not primarily liable

under 42 U.S.C. § 300aa-15(g), to the extent that payment has been made or can reasonably be

expected to be made under any State compensation programs, insurance policies, Federal or

                                                  3
State health benefits programs (other than Title XIX of the Social Security Act (42 U.S.C. §

1396 et seq.)), or by entities that provide health services on a pre-paid basis.

        14. Payments made pursuant to paragraph 8 and any amounts awarded pursuant to

paragraph 12 of this Stipulation will be made in accordance with 42 U.S.C. § 300aa-15(i),

subject to the availability of sufficient statutory funds.

        15. The parties and their attorneys further agree and stipulate that, except for any award

for attorneys’ fees and litigation costs, the money provided pursuant to this Stipulation will be

used solely for the benefit of E.S. as contemplated by a strict construction of 42 U.S.C.

§300aa-15(a) and (d), and subject to the conditions of 42 U.S.C. § 300aa-15(g) and (h).

        16. In return for the payments described in paragraphs 8 and 12, petitioner, in her

individual capacity and as legal representative of E.S., on behalf of herself, E.S., and her heirs,

executors, administrators, successors or assigns, do forever irrevocably and unconditionally

release, acquit and discharge the United States and the Secretary of Health and Human Services

from any and all actions or causes of action (including agreements, judgments, claims, damages,

loss of services, expenses and all demands of whatever kind or nature) that have been brought,

could have been brought, or could be timely brought in the Court of Federal Claims, under the

National Vaccine Injury Compensation Program, 42 U.S.C. § 300 aa-10 et seq., on account of, or

in any way growing out of, any and all known or unknown, suspected or unsuspected personal

injuries to or death of E.S. resulting from, or alleged to have resulted from, the vaccinations

administered on July 28, 2011, and September 28, 2011, as alleged by petitioner in a petition for

vaccine compensation filed on or about February 10, 2014, in the United States Court of Federal

Claims as petition No. 14-118V.

                                                   4
       17. If E.S. should die prior to entry of judgment, this agreement shall be voidable upon

proper notice to the Court on behalf of either or both of the parties.

       18. If the Special Master fails to issue a decision in complete conformity with the terms

of this Stipulation or if the Court of Federal Claims fails to enter judgment in conformity with a

decision that is in complete conformity with the terms of this Stipulation, then the parties’

settlement and this Stipulation shall be voidable at the sole discretion of either party.

       19. This Stipulation expresses a full and complete negotiated settlement of liability and

damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, except

as otherwise noted in paragraph 12 above. There is absolutely no agreement on the part of the

parties hereto to make any payment or to do any act or thing other than is herein expressly stated

and clearly agreed to. The parties further agree and understand that the award described in this

Stipulation may reflect a compromise of the parties’ respective positions as to liability and/or

amount of damages, and further, that a change in the nature of the injury or condition or in the

items of compensation sought, is not grounds to modify or revise this agreement.

       20. Petitioner hereby authorizes respondent to disclose documents filed by petitioner in

this case consistent with the Privacy Act and the routine uses described in the National Vaccine

Injury Compensation Program System of Records, No. 09-15-0056.

       21. This Stipulation shall not be construed as an admission by the United States or the

Secretary of Health and Human Services that the HPV vaccine caused E.S. to suffer chronic

urticaria or any other injury or condition.

       22. All rights and obligations of petitioner hereunder shall apply equally to petitioner’s

heirs, executors, administrators, successors, and/or assigns as legal representatives of E.S.

                                   END OF STIPULATION

                                                  5